The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4'-phosphate substituent - PubMed (original) (raw)
The lipooligosaccharide (LOS) of Neisseria meningitidis serogroup B strain NMB contains L2, L3, and novel oligosaccharides, and lacks the lipid-A 4'-phosphate substituent
M M Rahman et al. Carbohydr Res. 1998 Feb.
Abstract
The complete structure of the lipooligosaccharide (LOS) from Neisseria meningitidis strain NMB (serotype 2b:P1.2,5), a serogroup B cerebrospinal fluid isolate, was determined. Two oligosaccharide (OS) fractions and lipid-A were obtained following mild acid hydrolysis of the LOS. The structures in these fractions were determined using glycosyl composition and linkage analyses, N spectroscopy and mass spectrometry. One oligosaccharide fraction (OS1) consists of a molecule having a glycosyl sequence identical to that previously reported for the LOS from immunotype L2 N. meningitidis [A. Gamain, M. Beurret, F. Michon, J.-R. Brisson, and H.J. Jennings, J. Biol. Chem.,267,(112) 922-925] i.e., a lacto-N-neotetraose is attached to heptose I (Hep I), with terminally linked N-acetylglucosaminosyl and glucosyl residues attached to Hep II of the inner core. Approximately 70% of this structure is acetylated at O-6 of the terminally linked alpha-N-acetyl-glucosaminosyl residue. As with the L2 structure, the NMB LOS contained phosphoethanolamine (PEA) at O-6 or O-7 of the Hep II residue. The second oligosaccharide fraction (OS2) contains a a mixture of three different molecules, all of which vary from one another in their glycosyl substitution patterns of the Hep II residue. The most abundant molecule in OS2 has a structure identical to that of OSI, i.e., it has the L2 glycosyl sequence. A second molecule (OS2a) lacks the terminal glucosyl residue at O-3 of Hep II; i.e., it has a glycosyl sequence identical to that of the mild acid released oligosaccharide of N. meningitidis immunotype L3, L4, or L7 LOSs. The third molecule (OS2b) is a novel structure that lacks the terminal N-acetylglucosaminosyl residue linked to O-2 of Hep II. Overall, 76% of OS released from NMB LOS has the L2 structure, 15% is OS2a (L3), and 9% is OS2b. A portion (20%) of the molecules in the NMB LOS preparation also contained terminally linked sialic acid attached to O-3 of the lacto-N-neotetraose galactosyl residue, which is also consistent with the L3, or L4 LOS structures. In contrast to the previously reported structure of N. meningitidis lipid-A [V. A. Kulshin, U. Zähringer, B. Linder, C.E. Frasch, C-M. Tsai, B.A. Dmitriev, and E.T Rietschel, J. Bacteriol., 174, (1992)1793-1800], only 30% of the lipid-A from NMB LOS possesses 4'-phosphate. Comparison with the lipid-A of LOS purified from an isogenic acapsulate mutant, M7, revealed that the 4'-position was almost completely occupied with phosphate. These data emphasize the structural heterogeneity of the OS and phosphate substituents of Hep II, and 4'-phosphorylation of lipid-A of meningococcal LOS.
Similar articles
- The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491.
Choudhury B, Kahler CM, Datta A, Stephens DS, Carlson RW. Choudhury B, et al. Carbohydr Res. 2008 Nov 24;343(17):2971-9. doi: 10.1016/j.carres.2008.08.026. Epub 2008 Sep 2. Carbohydr Res. 2008. PMID: 18804756 Free PMC article. - Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes.
Kahler CM, Datta A, Tzeng YL, Carlson RW, Stephens DS. Kahler CM, et al. Glycobiology. 2005 Apr;15(4):409-19. doi: 10.1093/glycob/cwi018. Epub 2004 Dec 1. Glycobiology. 2005. PMID: 15574803 - The Many Facets of Lipooligosaccharide as a Virulence Factor for Histophilus somni.
Inzana TJ. Inzana TJ. Curr Top Microbiol Immunol. 2016;396:131-48. doi: 10.1007/82_2015_5020. Curr Top Microbiol Immunol. 2016. PMID: 26814887 Review.
Cited by
- Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway.
Zughaier SM, Tzeng YL, Zimmer SM, Datta A, Carlson RW, Stephens DS. Zughaier SM, et al. Infect Immun. 2004 Jan;72(1):371-80. doi: 10.1128/IAI.72.1.371-380.2004. Infect Immun. 2004. PMID: 14688118 Free PMC article. - Profiles of structural heterogeneity in native lipooligosaccharides of Neisseria and cytokine induction.
John CM, Liu M, Jarvis GA. John CM, et al. J Lipid Res. 2009 Mar;50(3):424-438. doi: 10.1194/jlr.M800184-JLR200. Epub 2008 Oct 2. J Lipid Res. 2009. PMID: 18832773 Free PMC article. - Acquisition of the capsule locus by horizontal gene transfer in Neisseria meningitidis is often accompanied by the loss of UDP-GalNAc synthesis.
Bartley SN, Mowlaboccus S, Mullally CA, Stubbs KA, Vrielink A, Maiden MC, Harrison OB, Perkins TT, Kahler CM. Bartley SN, et al. Sci Rep. 2017 Mar 14;7:44442. doi: 10.1038/srep44442. Sci Rep. 2017. PMID: 28290510 Free PMC article. - The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491.
Choudhury B, Kahler CM, Datta A, Stephens DS, Carlson RW. Choudhury B, et al. Carbohydr Res. 2008 Nov 24;343(17):2971-9. doi: 10.1016/j.carres.2008.08.026. Epub 2008 Sep 2. Carbohydr Res. 2008. PMID: 18804756 Free PMC article. - Biochemical analysis of Lpt3, a protein responsible for phosphoethanolamine addition to lipooligosaccharide of pathogenic Neisseria.
O'Connor ET, Piekarowicz A, Swanson KV, Griffiss JM, Stein DC. O'Connor ET, et al. J Bacteriol. 2006 Feb;188(3):1039-48. doi: 10.1128/JB.188.3.1039-1048.2006. J Bacteriol. 2006. PMID: 16428408 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials